Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company)

This study is testing an investigational oral medication called MORF-057 for adults with moderate to severe Crohn's disease. Researchers want to see if it can reduce intestinal inflammation and improve symptoms better than a placebo. Participants will receive the study drug or pl…

This is the first study to test a new drug called MORF-440 in people. It will enroll 80 healthy volunteers to check if the drug is safe and how the body handles it. Researchers will give different doses to small groups and closely monitor for any side effects.